News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Frazier Healthcare Acquires U.S. Commercial Pharmaceutical Packaging Operations from Catalent Pharma Solutions


6/20/2012 10:24:25 AM

SOMERSET, N.J., June 20, 2012 /PRNewswire/ -- Frazier Healthcare and Catalent Pharma Solutions, Inc., today announced they have closed the purchase and sale of Catalent's U.S. commercial pharmaceutical packaging operations based in Philadelphia, PA and Woodstock, IL to Frazier.

(Logo: http://photos.prnewswire.com/prnh/20120620/LA27475LOGO)

The business will be operated as Packaging Coordinators, Inc. ("PCI"). The former president of the business (from 2002-2006), Bill Mitchell, will again take the helm as president and chief executive officer. Re-joining Mr. Mitchell as part of the new PCI management team are Bill Bolding, as chief operating officer, and Phil DiGiacomo, as vice president of sales, each of whom have a longstanding history of success in both the industry and with PCI.

"This second act for PCI is not about nostalgia. We want to build on a strong foundation and reinvigorate PCI to once again become the supplier of choice for outsourced healthcare packaging," said Bill Mitchell, president and chief executive officer of Packaging Coordinators, Inc. "This management team knows growth is about focusing on the customer, including their mission critical milestones, timelines and business needs. The products create and drive the opportunity. The attention to quality and the focus on meeting the customers current and future needs will drive our growth."

Frazier Healthcare, founded in 1991 to invest exclusively in healthcare, is a leading provider of growth equity and venture capital to high growth and emerging healthcare companies.

"We are demonstrating our emphasis on a team approach at Frazier by empowering a known and passionate management team to create a reinvigorated model for healthcare packaging," said Alan Frazier, managing partner of Frazier Healthcare. "The acquisition of PCI gives us the opportunity to extend our model of uncovering opportunities where the combination of new a management team and an infusion of capital can result in outstanding growth and market leadership."

Catalent's decision to sell its U.S. commercial packaging operations is based on the company's business strategy to focus on growing its world leading businesses in development solutions and advanced delivery technologies, clinical trial supplies, advanced blow/fill/seal aseptic delivery technology, as well as offering integrated solutions for the development and supply of injectable biologics and complex pharmaceutical products. The acquisition does not involve Catalent's Clinical Supply Services operations adjacent to the Red Lion Road facility in Philadelphia, nor the Blow/Fill/Seal business in Woodstock.

"This sale is another step in advancing our strategy to focus on our leading drug development and delivery businesses in core segments," said Barry Littlejohns, president of Catalent's Medication Delivery Solutions segment. "We believe Frazier will be an excellent partner for the customers of the commercial packaging business."

About Packaging Coordinators, Inc.
Packaging Coordinators, Inc. offers unparalleled expertise in a range of proprietary pharmaceutical and biotechnology packaging innovations for healthcare clients across all markets. PCI leads the field in providing cutting-edge customized healthcare packaging solutions that improve patient adherence and uphold the most stringent safety requirements. For more information about PCI and its state of the art facilities in Philadelphia, PA and Woodstock, IL, visit the company's website at www.pciservices.com.

About Frazier Healthcare
Founded in 1991, Frazier Healthcare is a leading provider of growth equity and venture capital to high growth and emerging healthcare service and biopharma companies. With over $1.8 billion under management across seven funds, Frazier Healthcare has invested in more than 140 companies across the entire developmental spectrum. From seed stage venture investments to leveraged recapitalizations of cash generating companies, Frazier Healthcare has established itself among entrepreneurs and seasoned executives as a preferred partner to help create and grow successful healthcare companies. For more information about Frazier Healthcare, visit the company's website at www.frazierhealthcare.com.

About Catalent
From drug and biologic development services to delivery technologies to supply solutions, Catalent Pharma Solutions has the deepest expertise, the broadest offerings and the most unique technologies in the industry. With over 75 years of experience, Catalent helps customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging solutions. Catalent employs approximately 9,400 people at 29 facilities worldwide and in fiscal year 2011 generated more than $1.6 billion in annual revenue. Catalent is headquartered in Somerset, NJ. For more information, visit www.catalent.com.

more products. better treatments. reliably supplied.

PCI Contact:
Christine Cassiano
ARC2 Communications & Media, Inc.
Tel: 213-223-6178
Cell: 714-552-0326
Email: C2@ARC2Communications.com

Frazier Healthcare Contact:
Bridget D. Rauvola
Investor Relations & Marketing Partner
Frazier Healthcare
Tel: 206.973.8009
Cell: 303.775.2929
Email: bridget.rauvola@frazierhealthcare.com

CatalentPharma Solutions Contact:
Patricia McGee
Director, Global Marketing & Communications
Catalent Pharma Solutions
Tel: 732.537.6407
Cell: 610.745.5784
Email : patricia.mcgee@catalent.com

SOURCE Packaging Coordinators, Inc.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES